Melanoma
Conditions
Interventions
Index test:68Ga-ACLY-DE68Ga-ACC-DE68Ga-FASN-DE
Sponsors
The First Affiliated Hospital of the Air Force Medical University of the People's Liberation Army of China
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Age >= 18 years; (2) Pathologically confirmed melanoma, with planned surgical resection/exploration (including primary or recurrent metastatic tumours); (3) Estimated survival period > 3 months, as determined by the physician; (4) Voluntary signing of the informed consent form; willingness and ability to adhere to the study protocol.
Exclusion criteria
Exclusion criteria: (1) Individuals with a history of allergy to 68Ga-ACLY-DE/ACC-DE/FASN-DE or its excipients; (2) Individuals with alcohol allergy; (3) Individuals unable to tolerate intravenous administration (e.g., with a history of needle phobia or blood phobia); (4) Individuals unsuitable for or unable to complete PET or other imaging examinations due to specific reasons, including claustrophobia or radiophobia; (5) Pregnant or breastfeeding women; (6) Individuals requiring prolonged occupational exposure to radiation; (7) Those with severe cardiovascular, renal, pulmonary, vascular, neurological, psychiatric disorders, immunodeficiency diseases, or hepatitis/cirrhosis; (8) Participants who have enrolled in other interventional clinical trials within one month prior to screening; (9) Any other circumstances deemed unsuitable for participation in this study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Accuracy; | — |
Countries
China
Contacts
Public ContactJing Wang
The First Affiliated Hospital of the Air Force Medical University of the People's Liberation Army of China
Outcome results
None listed